Overview: Ibrance 100 mg (Palbociclib)
Ibrance 100 mg, containing the active ingredient Palbociclib, is a specialized oncology medication developed by Pfizer. Classified as a selective inhibitor of cyclin-dependent kinases 4 and 6 (CDK4/6), it is scientifically engineered to inhibit the progression of cancer cells in specific types of breast cancer.
Mechanism and Clinical Utility
Ibrance functions by inhibiting the CDK4/6 proteins, which are critical for the cell cycle and the proliferation of cancer cells. By effectively blocking these pathways, Ibrance helps to slow the growth and division of tumor cells. This targeted therapy is a significant component of modern oncology regimens for patients with hormone receptor-positive (HR+), HER2-negative (HER2-) advanced or metastatic breast cancer.
Key Therapeutic Benefits
- Targeted CDK4/6 Inhibition: Highly specific action that disrupts the cell cycle machinery, providing an effective way to manage tumor growth.
- Advanced Oncology Support: Designed to offer a precise treatment approach, often used in conjunction with endocrine therapy for comprehensive disease management.
- Clinical Reliability: Developed by Pfizer, a globally recognized leader in oncology, ensuring high standards of therapeutic quality and efficacy.
- Precise Dosing: Provided as 100 mg capsules, supporting accurate and flexible treatment plans as determined by your oncology specialist.
Product Details and Usage
Ibrance 100 mg is provided in a 21-capsule supply per unit, as shown. This packaging is designed to support the specific dosing schedules required for effective long-term breast cancer management, ensuring patients have consistent access to their prescribed therapy.
Safety and Storage Guidelines
Administration: Must be taken strictly as prescribed by your oncologist. Adjustments to therapy or dosing must be performed only by authorized medical professionals.
Storage: Store the capsules in their original packaging in a cool, dry place. Keep out of reach of children and ensure the storage environment remains within standard temperature limits.
Healthcare Collaboration: Maintain consistent communication with your oncology care team and the specialists at El-Masry Pharmacy to ensure optimal treatment outcomes and to address any clinical concerns promptly.
Disclaimer: Ibrance is a specialized, prescription-only oncology medication. Ensure you hold a valid prescription and consult with your healthcare provider before beginning any treatment plan.
You can add a rating once you purchase the product through the My Orders page
